BACKGROUND: FUN14 domain containing 1 (FUNDC1) is a highly conserved outer mitochondrial membrane protein. The aim of this study is to examine whether FUNDC1 modulates the mitochondriaassociated endoplasmic reticulum (ER) membranes (MAMs), mitochondrial morphology, and function in cardiomyocytes and intact hearts.
RESULTS:
In mouse neonatal cardiomyocytes and intact hearts, FUNDC1 was localized in MAMs by binding to ER-resided inositol 1,4,5-trisphosphate type 2 receptor (IP 3 R2). Fundc1 ablation disrupted MAMs and reduced the levels of IP 3 R2 and Ca 2+ in both mitochondria and cytosol, whereas overexpression of Fundc1 increased the levels of IP 3 R2 and Ca 2+ in both mitochondria and cytosol. Consistently, Fundc1 ablation increased Ca 2+ levels in ER, whereas Fundc1 overexpression lowered ER Ca 2+ levels. Further, Fundc1 ablation in cardiomyocytes elongated mitochondria and compromised mitochondrial functions. Mechanistically, we found that Fundc1 ablation-induced reduction of intracellular Ca 2+ levels suppressed mitochondrial fission 1 protein (Fis1) expression and mitochondrial fission by reducing the binding of the cAMP response element binding protein (CREB) 
CONCLUSIONS:
We conclude that FUNDC1 binds to IP 3 R2 to modulate ER Ca 2+ release into mitochondria and cytosol. Further, a disruption of the FUNDC1 and IP 3 R2 interaction lowers the levels of Ca 2+ in mitochondria and cytosol, both of which instigate aberrant mitochondrial fission, mitochondrial dysfunction, cardiac dysfunction, and heart failure.
M
itochondria and endoplasmic reticulum (ER) are interconnected organelles, both of which form an endomembrane network. 1 These contact points where ER communicates with mitochondria are referred to as mitochondria-associated ER membranes (MAMs). 1 These physical interactions between both organelles depend on complementary membrane proteins, which tether the 2 organelles together at specific sites. For example, the voltage-dependent anion channel 1 of the outer mitochondrial membrane interacts with the inositol 1,4,5-triphosphate type 1 receptor on the ER through the molecular chaperone glucose-regulated protein 75, allowing Ca 2+ transfer from the ER to mitochondria. 2 The σ-1 receptor stabilizes MAMs by interacting with inositol 1,4,5-triphosphate type 1 receptor and voltage-dependent anion channel 1. 3 Mitofusin 2 (Mfn2) has been proposed to be an additional physical tether. 4, 5 Although numerous proteins have been identified in MAMs fractions, factors that control the formation and functions of MAMs are still poorly understood. Increasing evidence suggests that MAMs function as a center for intermembrane transport of phospholipids, and MAMs are crucial to shape intracellular Ca 2+ signaling and regulate mitochondrial bioenergetics. 2, 6 As a result, dysfunctional MAMs are involved in the pathogenesis of neuronal disorders, such as Alzheimer 7 and Parkinson 8 diseases. However, the roles of MAMs in cardiac physiology and pathologies remain poorly characterized. Mitochondria are critical integrators of energy production, reactive oxygen species generation, signal transduction, and apoptosis. 9 Because the myocardium is a high-energy-demand tissue, mitochondria play a central role in maintaining optimal cardiac performance. [10] [11] [12] Although mitochondrial fission and fusion are most evident in neonatal cardiomyocytes because of the features of perinatal cardiac metabolic maturation, [13] [14] [15] strong evidence suggests that these processes are important in the adult cardiac tissue. [16] [17] [18] [19] Indeed, growing evidence suggests that deregulated mitochondrial dynamics play a causative role in cardiovascular diseases. [20] [21] [22] [23] [24] [25] [26] To maintain normal structure and function, mitochondria continuously join by the process of fusion and divide by the process of fission, so-called mitochondrial dynamics. 27 The execution of mitochondrial dynamics in mammalian cells requires the participation of a large number of proteins, including mitofusin 1/2 (Mfn1/2) and optic atrophy 1 as fusion proteins and dynamin-related protein 1 (DRP1), mitochondrial fission factor, and mitochondrial fission 1 protein (Fis1) as fission proteins. Recently, MAMs have been highlighted to play an important role in mitochondrial fission process by marking the division sites.
FUN14 domain containing 1 (FUNDC1), an outer mitochondrial membrane protein with 155 amino acids, is highly conserved from Drosophila to humans. 28 FUNDC1 contains a hydrophobic transmembrane domain consisting of 3 α-helical stretches with its amino terminus exposing to the cytosol and its carboxyl terminus stretching in the intermembrane space. 28 Recent studies report that FUNDC1 localizes in MAMs of HeLa cells. 29, 30 However, whether FUNDC1 regulates MAMs formation and influences MAMs function is unknown. Furthermore, the expression of Fundc1 in cardiac tissues and its functions remain poorly studied. Here we report that FUNDC1 binds to inositol 1,4,5-trisphosphate type 2 receptor (IP 3 R2), a key player that is responsible for Ca 2+ release from the ER into mitochondria and cytosol. As a result, cardiac-specific Fundc1 ablation instigates aberrant mitochondrial network, mitochondrial dysfunction, cardiac dysfunction, and heart failure. 
METHODS

Generation of the Cardiomyocyte-Specific
What Are the Clinical Implications?
• The FUNDC1-mediated mitochondria-associated endoplasmic reticulum membranes formation was significantly suppressed in the patients with heart failure, supporting that FUNDC1 and mitochondria-associated endoplasmic reticulum membranes actively participate in the development of heart failure.
• Restoring the proper function of mitochondriaassociated endoplasmic reticulum membranes may be a novel target for treating heart failure.
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Statistics
All the data were expressed as mean±SD. All experiments were performed at least in triplicate unless otherwise stated. Homogeneity of the variance was assessed via the F test (2 groups) or the Brown-Forsythe test (≥3 groups). Normality of the data was assessed via the Shapiro-Wilk test. When reporting results with 2 groups, we used standard the Student t test when the assumptions (equal variance and normal distribution) were satisfied. Otherwise, the nonparametric Mann-Whitney U test was applied to analyze the difference between 2 groups. In the results with more than 2 groups, ANOVA or appropriate nonparametric tests were applied to analyze the difference. When 1 factor was involved, we used 1-way ANOVA followed by the Bonferroni post hoc test when the assumptions (equal variance and normal distribution) were satisfied. Otherwise, we used the nonparametric Kruskal-Wallis test followed by the Dunn post hoc test to correct for multiple comparisons. In results with 2 factors, 2-way ANOVA followed by the Bonferroni post hoc test was applied for multiple comparisons when the assumptions (equal variances and normal distribution) were stratified. Otherwise we used the nonparametric Scheirer-Ray-Hare test (an extension of the Kruskal-Wallis test) followed by the Dunn post hoc test to correct for multiple comparisons. The P values were adjusted for multiple comparisons where appropriate. P values <0.05 were considered statistically significant. All statistical analyses were carried out using SPSS Version 21 software.
Study Approval
The animal protocol in this study was approved by the Institutional Animal Care and Use Committee at Georgia State University. All human studies were approved by the human ethics committee of Wuhan Union Hospital of Huazhong University of Science and Technology (2017-S10005), and the subjects gave informed consent.
RESULTS
Cardiomyocyte-Specific Deletion of Fundc1 Induces Mitochondrial Elongation and Heart Failure in Vivo
We first examined the distribution of FUNDC1 in different organs of mouse. As shown in Figure IA in the online-only Data Supplement, mouse heart expressed higher levels of Fundc1. In cardiac tissue, FUNDC1 appeared to be exclusively localized within the mitochondria ( Figure IB in Figure 1A and B), which was concurrent with an increase in the deceleration time of the E-wave ( mice also exhibited impaired systolic functions. As presented in Figure 1I , 
Fis1 Is Essential for FUNDC1-Induced Mitochondrial Fission in Cardiomyocytes
To establish the role of FUNDC1 in mitochondrial dynamics, we used time-lapse confocal imaging to measure mitochondrial fusion and fission in live neonatal cardiomyocytes. Figure 3A and B). The proportion of fission events (assay as the ratio of fission/[fission + fusion] events) also decreased in Figure 3C ). These data suggested that Fundc1 knockout resulted in decreased mitochondria fission.
To gain insights into how FUNDC1 regulates mitochondrial dynamics, we investigated whether FUNDC1 altered the expression of mitochondrial dynamicsrelated proteins in cardiomyocytes. Fundc1 knockout reduced Fis1 protein levels in the heart ( Figure 3D and E). In contrast, adenoviral overexpression of Fundc1 in mouse neonatal cardiomyocytes increased Fis1 abun- ). F, The neonatal cardiomyocytes were infected with adenovirus encoding β-galactosidase (ad-β-Gal) or FUNDC1 (ad-Fundc1) for 48 hours. Protein levels of Fis1, DRP1, MFF, OPA1, Mfn1/2, and FUNDC1 were measured by Western blot. G, Densitometric analysis of the protein levels in F (mean±SD, n=5 independent experiments; **P<0.01 vs. ad-β-Gal).
dance ( Figure 3F and G). Unexpectedly, neither overexpression nor ablation of Fundc1 affected the protein levels of DRP1, mitochondrial fission factor, Mfn1/2, and optic atrophy 1 ( Figure 3D -G). Similar results were also observed in cultured rat cardiac myoblasts (H9c2) with Fundc1 silencing ( Figure IV in the online-only Data Supplement). These results suggest that FUNDC1 selectively regulates Fis1 in cardiomyocytes.
We next determined the contributions of Fis1 in FUNDC1-induced mitochondrial fission in H9c2 myo- /Cre αMyHC+/− neonatal cardiomyocytes were transfected with GFP-Fis1 or control GFP plasmid. Oxygen consumption rate (OCR) was determined using a Seahorse flux analyzer. F, Basal respiration, proton leak, and maximal respiration were determined (mean±SD, n=5 independent experiments; *P<0.05 vs. Fis1 has been reported to recruit DRP1 into mitochondria, inducing mitochondrial fragmentation. To determine whether DRP1 mediates FUNDC1-regulated mitochondrial dynamics, we first determined whether FUNDC1 physically interacts with DRP1. As depicted in Figure . Taken together, these data indicate that no physical interaction exists among FUNDC1, Fis1, and DRP1. DRP1 phosphorylation is important in its cytosol to mitochondrial translocation. 31 To this end, we tested potential influence of FUNDC1 on DRP1 phosphorylation. It is interesting to note that Fundc1 overexpression failed to alter DRP1 phosphorylation at both serine 616 and serine 637 ( Figure VID and E in the online-only Data Supplement), 2 phosphorylation sites important for DRP1-mediated mitochondrial fission. 31 Consistently, Fundc1 overexpression did not alter the distributions of DRP1 in cytosolic and mitochondrial fractions ( Figure  VIF in the online-only Data Supplement).
Fis1 Is Essential for FUNDC1-Induced Mitophagy in Cardiomyocytes
Because mitochondrial fission is essential for cells to undergo mitophagy 32, 33 and FUNDC1-promoted mitochondrial fission, we next examined whether FUNDC1 mediates mitophagy in cardiomyocytes by assaying mt-Keima, a ratiometric pH-sensitive fluorescent protein that is targeted into the mitochondrial matrix. 34 The method was validated by showing that carbonyl cyanide-4-(trifluoromethoxy)phenylhydrazone enhanced mitophagy in cardiomyocytes ( Figure  VIIA and B in the online-only Data Supplement). As described in Figure VIIC and D in the online-only Data Supplement, adenoviral overexpression of Fundc1 but not β-Gal significantly increased the incidence of red mt-Keima puncta (lysosome-localized mitochondria), indicating that FUNDC1 promoted mitophagy. It is important to know that Fis1 knockdown abolished enhanced mitophagy mediated by 
FUNDC1 Regulates Fis1 at the Transcriptional Level by Activating CREB in a Ca
2+ -Dependent Manner
To elucidate how FUNDC1 regulates Fis1, we first examined whether the ubiquitin-proteasome pathway was involved in regulating Fis1 protein turnover. To this end, mouse neonatal cardiomyocytes and H9c2 myoblasts were treated with MG132, a potent proteasome inhibitor. As shown in Figure XA and B in the online-only Data Supplement, MG132 had no effect on Fis1 protein levels in cells. In addition, MG132 did not ablate the cAMP response element binding protein (CREB) is an ubiquitous transcription factor that can promote the expression of mitochondrial genes. 35 Therefore, we investigated whether CREB was involved in FUNDC1-induced Fis1 expression. First, we examined whether FUNDC1 regulates CREB phosphorylation in the heart and found that Fundc1 deletion resulted in decreased phosphorylation of CREB at Ser133 ( Figure XIB Next, we assayed how FUNDC1 promotes the activation of CREB. CREB activation is generally associated with the activation of protein kinase A (PKA). To test the role of PKA on the regulation of CREB by FUNDC1, we pharmacologically inhibited PKA activity in Fundc1-overexpressing cardiomyocytes with a PKA inhibitor H89. As depicted in Figure XIII in the online-only Data Supplement, H89 did not affect CREB phosphorylation and Fis1 expression, suggesting a PKA-independent CREB activation.
Given that CREB is required by FUNDC1-mediated To verify the specific binding location of CREB within Fis1 promoter, a 749-bp region from human Fis1 promoter that includes the CREB binding site was cloned into the luciferase vector pGL-3, and then a serial titration of luciferase plasmids with a different length of the promoter of human Fis1 was transfected into HEK293T cells ( Figure XIVG in the online-only Data Supplement). Two luciferase plasmids with -477-bp site deletion were also generated, resulting in pGL-Fis1-749Del and pGL-Fis1-558Del. As shown in Figure XIVH in Figure 5I and J) in cardiomyocytes. Therefore, we hypothesized that Fundc1 ablation inhibited the Ca 2+ release from the ER to the mitochondria and cytosol.
Because inositol 1,4,5-trisphosphate receptors (IP 3 Rs) are important ER Ca 2+ release channels, 6 we assayed whether knockdown of Ip 3 rs affected FUNDC1-altered calcium homeostasis. As depicted in Figure 5G- Figure 5L and M) . Taken together, these results indicate that FUNDC1 regulates Ca 2+ release from ER to mitochondria and cytosol.
The regulation of calcium flux between the ER and mitochondria via IP 3 Rs is a major function of MAMs. 36 Because FUNDC1's localization in MAMs has been reported in HeLa cells, 29, 30 several steps were taken to determine whether FUNDC1's effects on intracellular calcium homeostasis in cardiomyocytes are dependent on MAMs formation. First, we detected FUNDC1 subcellular localization. As illustrated in Figure 6A and B and Figure XV in the online-only Data Supplement, FUNDC1 colocalized with both mitochondria and ER, indicating that FUNDC1 is associated with MAMs, which was further verified by subcellular fractionation ( Figure 6C) Figure 6D , Figure XVI in the online-only Data Supplement). In Fundc1 f/Y /Cre αMyHC+/− cardiomyocytes, the ER became aggregated and swollen, whereas mitochondria became longer and more interconnected ( Figure 6D , Figure XVI in (Figure 6E) . Consistently, Fundc1 silencing reduced colocalization of ER and mitochondria in H9c2 myoblasts (Figure XVII in the online-only Data Supplement). We also used transmission electron microscopy to determine the alterations in MAMs formation. We observed that Fundc1 deficiency reduced the association between ER and mitochondria in the heart ( Figure 6F ). Quantitative analysis showed that the proportion of the ER adjacent to the mitochondria was significantly reduced in the 
Acute Myocardial Infarction Exacerbates Heart Failure Phenotype in Cardiac Fundc1 Knockout Mice
We found that the heart failure phenotype by Fundc1 ablation became apparent in 10-week-old mice, and this phenotype became more obvious as the age increased. However, these mice at 8 weeks of age appeared to have normal cardiac functions, as shown by echocardiography (Table I in the online-only Data Supplement). Therefore, we sought to know whether heart attack challenge could exacerbate the heart failure phenotype in Fundc1-ablated mice. To this end, we subjected 8-week-old αMyHC+/− mice died at day 4 after MI challenge, and the mortality was ≤62.5% 4 weeks after MI (Figure 7F) . Overall, our results indicate that heart attack challenge exacerbates the heart failure phenotype in Fundc1-ablated mice.
We next explored whether the exacerbation of heart failure was correlated with the further downregulation of FUNDC1/MAMs/CREB/Fis1 signaling by MI treatment. To this end, we examined the levels of FUNDC1/MAMs/CREB/Fis1 signaling in each group.
The MI reduced FUNDC1 protein levels, concurrent with a reduction in MAMs-related proteins (IP 3 R2 and PACS-2), phosphorylated CREB, and Fis1 ( Figure 7G ). In Figure 7G ). Overall, our results indicate that MI exacerbates heart failure phenotype in cardiac Fundc1-ablated mice likely via its suppression of MAMs formation.
Downregulation of FUNDC1/MAMs/ CREB/Fis1 Signaling in Human Patients With Heart Failure
To further establish whether FUNDC1 reduction occurred in human hearts as well as its contributions in patients with heart failure, 4 heart specimens from patients with heart failure and 4 from control donors were examined. As depicted in Figure 8A and B, concurrent with a reduction in MAMs-related proteins, including inositol 1,4,5-triphosphate type 1 receptor and inositol 1,4,5-trisphosphate type 3 receptor, the levels of FUNDC1, phosphorylated CREB, and Fis1 were significantly reduced in patients with heart failure compared with control donors. As expected, a reduced association between ER and mitochondria occurred in failed hearts ( Figure 8C ). The proportion of the ER adjacent to mitochondria was significantly reduced in patients with heart failure ( Figure 8D ). Compared with the ovoid structure of mitochondria in donor hearts, mitochondria in heart failure hearts were more elongated ( Figure 8C and E). Taken together, reduced FUNDC1 is linked to reduce IP 3 Rs, decreased CREB/Fis1 signaling, elongated mitochondria, and reduced contact between ER and mitochondria.
DISCUSSION
In the present study, for the first time we have found that MAMs-localized FUNDC1 binds to IP 3 R2 to mediate IP 3 Rs-dependent Ca 2+ release from ER into both mitochondria and cytosol in cardiomyocytes. This re- Fundc1 impairs cardiac functions, associated with mitochondrial elongation and accumulation of dysfunctional mitochondria. Fifth, acute MI reduced Fundc1 expression and exacerbated the heart failure phenotype in Fundc1 knockout mice. Finally, Fundc1 expression was decreased in hearts from the patients who were diagnosed with dilated cardiomyopathy. Concomitantly, the contact between ER and mitochondria was largely reduced, along with the reduction in MAMs proteins and the CREB/Fis1 signaling. Taken together, our results support a key role of FUNDC1 in maintaining normal mitochondrial function and morphology in , and mitochondrial Fis1 in human heart specimens from donor or patients with heart failure were determined by Western blot. MW indicates molecular weight. B, Densitometric analysis of the protein levels in A (mean±SD, n=4; *P<0.05, **P<0.01 vs. donor). C, Representative transmission electron microscopy (TEM) images indicating the endoplasmic reticulum (ER) and mitochondrial contacts in the human hearts of donors and heart failure patients. Asterisks indicate mitochondria; pound signs indicate ER. Scale bars, 1 μm. D, Quantification of the ER adjacent to mitochondria in the heart was normalized by total ER perimeter (mean±SD, n=4; **P<0.01 vs. donor). E, Mitochondrial length and width (mean±SD, n=4; **P<0.01 vs. donor). 40 Further, deletion of all 3 isoforms of IP 3 Rs diminishes mitochondrial Ca 2+ uptake, leading to compromised mitochondrial function. 41 It is important to note that the basal oxygen consumption rate was lower by 60% in 1,4,5-triphosphate type 1 receptor knockout cells compared with wild-type cells. Maximal oxygen consumption rate was also highly reduced in Fundc1-deficient cells. 41 However, our result is not consistent with the report in Mfn2 (a MAMs structural protein) knockout cells showing inhibited mitochondrial Ca 2+ uptake and increased intracellular Ca 2+ levels. 4 In Mfn2 knockout cells, 4 the mitochondrial Ca 2+ uptake was inhibited because of the disassociation of ER and mitochondria, but without any effect on ER Ca 2+ release capacity, and therefore intracellular Ca 2+ levels were increased. The precise molecular mechanism of how FUNDC1 regulates IP 3 Rs Ca 2+ release channel activity warrants further investigation.
Another important finding of the present study is that we have for the first time uncovered a novel pathway by which increased MAMs activates a Ca 2+ -sensitive CREB transcription factor to directly bind the promoter of Fis1 resulting in its gene transcription. In our context, Ca 2+ serves as a mediator to facilitate FUNDC1 to induce fission and mitophagy processes, suggesting a remarkable pathway that occurs in Ca 2+ -sensitized organs, particularly in cardiac muscle. The changes in intracellular Ca 2+ concentration serve as a retrograde signal that activates a nuclear transcription factor, CREB, which can directly regulate Fis1 transcription. Our evidence is summarized as follows. First, we observed that Fis1 expression was positively regulated by FUNDC1, without any effect on the protein levels of other mitochondrial dynamic machinery proteins. Second, genetic studies indicate that FUNDC1 and Fis1 work on the same pathway to induce mitochondrial fission, and FUNDC1 acts upstream of Fis1 because overexpression of Fis1 in Fundc1-deficient cells rescued the Fundc1 mutant phenotype, whereas overexpression of Fundc1 failed to do so in Fis1-deficient cells. Finally, we have found that Fundc1 overexpression could not increase Fis1 expression in CREB-deficient cells. Our findings strongly support the notion that MAMs serve as an important signaling hub regulating mitochondrial dynamics, not only by providing a potential fission site that has been previously reported, 38, 42 but also by regulating dynamics-related gene expression at the transcriptional levels. Another important finding of our study is that FUNDC1-upregulated Fis1 facilitates mitophagy. Indeed, overexpression of Fundc1 increased mitochondrial fragmentation, accompanied by increased mitophagy. Inhibition of mitochondrial fission by gene silencing of Fis1 abolished the mitophagy in the cells overexpressing Fundc1. Our findings suggest that FUNDC1 induces mitophagy by acting as a mitophagy receptor and enhancing mitochondrial fragmentation.
Several studies suggested CREB as an important regulator of gene expression involved in the pathophysiology of heart failure. [43] [44] [45] [46] However, CREB in cardiomyocyte mitochondrial dynamics has not been studied yet. We reported here that the phosphorylation levels of CREB at the site of Ser133 were significantly decreased in the hearts of cardiac-specific Fundc1 knockout mice, along with elongated mitochondria and typical cardiac dysfunction. The chromatin immunoprecipitation assay further indicates that CREB binds to the promoter sequence of Fis1, the expression of which is important for mitochondrial dynamics in cardiomyocytes. 47 With a luciferase assay method, we further observed that CREB increased Fis1 promoter activity. These results implicate that CREB was involved in the pathophysiology of disordered mitochondrial dynamics-associated cardiomyopathy by regulating mitochondrial dynamic machinery gene Fis1 expression. The finding of CREB as a transcription factor for Fis1 largely extends the knowledge on how Fis1 expression is regulated. Wang et al 47 showed that Fis1 protein level was negatively regulated by miR-484, which could be transactivated by forkhead box O3. In our experimental system, we used a silencer to decrease forkhead box O3, but we could not see any change in Fis1 expression (data not shown). Another work identified Fis1's proteasomal degradation by DJ-1 signaling in neurons by activating a RNF5 E3-ligase. 48 However, we could not observe any change in Fis1 expression with different doses of MG132, a specific proteasome inhibitor, even after an extended incubation time of 24 hours.
A recent study in HeLa cells shows that Ca 2+ controls mitochondrial dynamics by regulating DRP1 phosphorylation and mitochondrial translocation via activating calcium/calmodulin-dependent kinase II α. 49 However, DRP1 appears not to be required for FUNDC1-induced mitochondrial fission in cardiomyocytes. First, no physical interaction occurs between FUNDC1 and DRP1 in cardiomyocytes. Second, overexpression of Fundc1 failed to alter DRP1 protein expression and DRP1 phosphorylation. Although Fundc1 overexpression dramatically increased Fis1 protein levels, it failed to promote the mitochondrial translocation of DRP1 as well as the interaction between DRP1 and Fis1. These results suggest that Fis1 works on mitochondrial dynamics in a DRP1-independent manner in cardiomyocyte. Consistent with our findings, no detectable interaction was found between purified DRP1 and hFis1. 50, 51 Increased or reduced levels of hFis1 do not alter mitochondrial translocation of DRP1 in HeLa cells. 52 Because Fis1 is not a GTPase and cannot directly drive mitochondrial fission, some additional protein(s) should work together with Fis1 to accomplish the mitochondrial fission process. A recent study showed that mammalian Fis1 recruits the GTPase regulator domain-containing protein TBC1D15 and functions in mitochondrial morphology regulation independent of DRP1. 53 However, we did not find any association between Fis1 and TBC1D15 in cardiomyocytes. Dynamin II is a fundamental component of the mitochondria, which has recently been defined to recruit to mitochondrial fission sites to facilitate the fission process. 54 It is likely that Fis1 may function as the receptor of dynamin II. The molecular function of Fis1 in mammalian mitochondrial morphology regulation warrants further investigation. In summary, in this study, we found that FUNDC1 reduction inhibits the integrity of MAMs, and the MAMs-localized FUNDC1 regulates calcium concentrations in mitochondria and cytosol by regulating the levels and functions of IP 3 R2. The reduction of FUNDC1 in MAMs results in lower [Ca 2+ ] m and [Ca 2+ ] i , which in turn leads to inhibition of the CREB/Fis1 pathway, elongation of mitochondria, impaired mitochondrial function, and consequent cardiac dysfunction in the heart (Figure XX in the online-only Data Supplement). We conclude that FUNDC1 is essential in maintaining functional mitochondria and normal cardiac function. Deregulated FUNDC1 in cardiomyocytes via abnormal MAMs plays a causative role in the development of heart disease. 
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